We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNAB
101
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$838K 0.09%
83,220
QDROU
102
DELISTED
Quadro Acquisition One Corp. Unit
QDROU
$821K 0.09%
+81,326
New +$812K
RBT
103
DELISTED
Rubicon Technologies, Inc.
RBT
$784K 0.08%
+55,066
New +$870K
GCTS
104
GCT Semiconductor Holding
GCTS
$225M
$754K 0.08%
+74,000
New +$746K
LNZA icon
105
LanzaTech
LNZA
$70.1M
$726K 0.08%
727
-376
-34% -$371K
BIIB icon
106
Biogen
BIIB
$30.6B
$692K 0.07%
2,500
-8,425
-77% -$2.38M
KVSA
107
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$679K 0.07%
68,000
-101
-0.1% -$1K
MSAI icon
108
MultiSensor AI
MSAI
$10.8M
$668K 0.07%
+1,638
New +$661K
SGII
109
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$651K 0.07%
+63,853
New +$644K
YTPG
110
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$634K 0.07%
+64,547
New +$635K
SLGC
111
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$621K 0.06%
247,226
MAXR
112
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$587K 0.06%
+20,000
New +$549K
NVSA
113
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$561K 0.06%
+55,532
New +$555K
CRESW
114
DELISTED
Cresud SACIF y A. Warrant
CRESW
$544K 0.06%
1,601,182
+295,518
+23% +$118K
DNAD
115
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$542K 0.06%
53,900
-10,239
-16% -$102K
COCH icon
116
Envoy Medical
COCH
$54.3M
$532K 0.06%
+53,054
New +$528K
BSGA
117
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$523K 0.05%
50,000
-3,401
-6% -$35.2K
MAXR
118
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$517K 0.05%
10,000
-10,000
-50% -$274K
AMZN icon
119
PUT
Amazon
AMZN
$3T
$508K 0.05%
+30,000
New +$2.96M
KRNL
120
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$506K 0.05%
+50,100
New +$502K
BITE
121
DELISTED
Bite Acquisition Corp.
BITE
$504K 0.05%
+50,000
New +$499K
UHG
122
DELISTED
United Homes Group
UHG
$503K 0.05%
+50,000
New +$498K
PMGMU
123
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$502K 0.05%
+50,000
New +$498K
FITB
124
Fifth Third Bancorp
FITB
$51.8B
$501K 0.05%
15,265
-101,819
-87% -$3.48M
AWAY icon
125
Amplify Travel Tech ETF
AWAY
$32.3M
$470K 0.05%
28,490
-1,006
-3% -$16.4K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.